JP2011524887A5 - - Google Patents

Download PDF

Info

Publication number
JP2011524887A5
JP2011524887A5 JP2011514119A JP2011514119A JP2011524887A5 JP 2011524887 A5 JP2011524887 A5 JP 2011524887A5 JP 2011514119 A JP2011514119 A JP 2011514119A JP 2011514119 A JP2011514119 A JP 2011514119A JP 2011524887 A5 JP2011524887 A5 JP 2011524887A5
Authority
JP
Japan
Prior art keywords
retroviral vector
formulation
ultrafiltration
filter
sterilization
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011514119A
Other languages
English (en)
Japanese (ja)
Other versions
JP5615271B2 (ja
JP2011524887A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/GB2009/001527 external-priority patent/WO2009153563A1/en
Publication of JP2011524887A publication Critical patent/JP2011524887A/ja
Publication of JP2011524887A5 publication Critical patent/JP2011524887A5/ja
Application granted granted Critical
Publication of JP5615271B2 publication Critical patent/JP5615271B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011514119A 2008-06-18 2009-06-18 ウイルス精製法 Active JP5615271B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7368508P 2008-06-18 2008-06-18
US61/073,685 2008-06-18
PCT/GB2009/001527 WO2009153563A1 (en) 2008-06-18 2009-06-18 Virus purification

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014142447A Division JP6002720B2 (ja) 2008-06-18 2014-07-10 ウイルス精製法

Publications (3)

Publication Number Publication Date
JP2011524887A JP2011524887A (ja) 2011-09-08
JP2011524887A5 true JP2011524887A5 (https=) 2012-07-19
JP5615271B2 JP5615271B2 (ja) 2014-10-29

Family

ID=40940324

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2011514119A Active JP5615271B2 (ja) 2008-06-18 2009-06-18 ウイルス精製法
JP2014142447A Expired - Fee Related JP6002720B2 (ja) 2008-06-18 2014-07-10 ウイルス精製法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2014142447A Expired - Fee Related JP6002720B2 (ja) 2008-06-18 2014-07-10 ウイルス精製法

Country Status (8)

Country Link
US (1) US9169491B2 (https=)
EP (2) EP3192874B1 (https=)
JP (2) JP5615271B2 (https=)
CN (2) CN102124115B (https=)
DK (2) DK3192874T3 (https=)
ES (2) ES2762864T3 (https=)
PL (2) PL2307551T3 (https=)
WO (1) WO2009153563A1 (https=)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2529020T3 (en) * 2010-01-28 2018-08-06 Childrens Hospital Philadelphia SCALABLE PREPARATION PLATF FOR CLEANING VIRAL VECTORS AND CLEANED VIRAL VECTORS FOR USE IN GENTHERAPY
CN102946907A (zh) 2010-05-28 2013-02-27 牛津生物医学（英国）有限公司 慢病毒载体向脑的递送
GB201118636D0 (en) 2011-10-28 2011-12-07 Oxford Biomedica Ltd Nucleotide sequence
PT2782997T (pt) 2011-11-24 2018-04-09 Genethon Sistema de produção de vetor lentiviral escalável compatível com aplicações farmacêuticas industriais
US20140349403A1 (en) 2011-12-12 2014-11-27 The Children's Hospital Of Philadelphia Large commercial scale lentiviral vector production system and vectors produced thereby
WO2013106398A1 (en) * 2012-01-09 2013-07-18 Sanofi Pasteur Biologics, Llc Purification of herpes virus
WO2013177172A2 (en) 2012-05-21 2013-11-28 Sanofi Pasteur Limited Herpesvirus compositions and related methods
SI3889173T1 (sl) 2013-02-15 2023-11-30 Bioverativ Therapeutics Inc. Optimiran gen dejavnika VIII
RU2709678C2 (ru) * 2013-03-15 2019-12-19 Дзе Чилдрен'З Хоспитал Оф Филадельфия Масштабный производственный способ получения рекомбинантных лентивирусных векторов в системе культивирования клеток в бессывороточной суспензии
FR3010720B1 (fr) 2013-09-16 2017-08-11 Genethon Procede de production de virus enveloppes
FR3014901B1 (fr) 2013-12-17 2017-06-09 Genethon Procede de purification de virus ou vecteurs viraux enveloppes
GB201322798D0 (en) 2013-12-20 2014-02-05 Oxford Biomedica Ltd Production system
EP3160478A4 (en) 2014-06-30 2018-05-16 Bioverativ Therapeutics Inc. Optimized factor ix gene
CN104371982A (zh) * 2014-10-21 2015-02-25 武汉维诺赛生物技术有限公司 一种慢病毒的纯化方法
ES2904301T3 (es) 2014-11-03 2022-04-04 Academisch Ziekenhuis Leiden H O D N Leids Univ Medisch Centrum Receptores de células T dirigidos contra Bob1 y usos de los mismos
EP3054007A1 (en) 2015-02-09 2016-08-10 Institut National De La Sante Et De La Recherche Medicale (Inserm) Recombinant adeno-associated virus particle purification comprising an immuno-affinity purification step
JP2018510627A (ja) 2015-03-10 2018-04-19 レイデン ユニバーシティ メディカル センター メラノーマ優先発現抗原に対して向けられたｔ細胞レセプターおよびその使用
US10711282B2 (en) 2015-11-23 2020-07-14 Novartis Ag Optimized lentiviral transfer vectors and uses thereof
WO2017136358A1 (en) 2016-02-01 2017-08-10 Bioverativ Therapeutics Inc. Optimized factor viii genes
CN107043784A (zh) * 2016-02-05 2017-08-15 上海吉凯基因化学技术有限公司 一种慢病毒载体的制备方法
JP2019519250A (ja) 2016-05-10 2019-07-11 ユナイテッド ステイツ ガバメント アズ リプレゼンテッド バイ ザ デパートメント オブ ベテランズ アフェアーズＵｎｉｔｅｄ Ｓｔａｔｅｓ Ｇｏｖｅｒｎｍｅｎｔ Ａｓ Ｒｅｐｒｅｓｅｎｔｅｄ Ｂｙ Ｔｈｅ Ｄｅｐａｒｔｍｅｎｔ Ｏｆ Ｖｅｔｅｒａｎｓ Ａｆｆａｉｒｓ Ｈｉｖ−１感染と複製に必須な遺伝子を切断するｃｒｉｓｐｒ／ｃａｓの構築物のレンチウィルスによる送達
GB201614050D0 (en) * 2016-08-17 2016-09-28 Glaxosmithkline Ip Dev Ltd Method for purifying viral vectors
MA50877A (fr) 2017-11-21 2020-09-30 Bayer Healthcare Llc Matériaux et méthodes pour le traitement de la rétinite pigmentaire autosomique dominante
WO2019123429A1 (en) 2017-12-21 2019-06-27 Casebia Therapeutics Llp Materials and methods for treatment of usher syndrome type 2a
WO2019123430A1 (en) 2017-12-21 2019-06-27 Casebia Therapeutics Llp Materials and methods for treatment of usher syndrome type 2a and/or non-syndromic autosomal recessive retinitis pigmentosa (arrp)
EP3633040B1 (en) 2017-12-22 2023-06-07 Oxford BioMedica (UK) Limited Retroviral vector
JP2021520232A (ja) * 2018-04-05 2021-08-19 オックスフォード ユニバーシティ イノベーション リミテッドＯｘｆｏｒｄ Ｕｎｉｖｅｒｓｉｔｙ Ｉｎｎｏｖａｔｉｏｎ Ｌｉｍｉｔｅｄ 黄斑ジストロフィーを処置するための組成物及び方法
US11529413B2 (en) 2018-06-12 2022-12-20 Kbio Holdings Limited Virus and antigen purification and conjugation
US11690907B2 (en) 2018-06-12 2023-07-04 Kbio Holdings Limited Vaccines formed by virus and antigen conjugation
US11696948B2 (en) 2018-06-12 2023-07-11 Kbio Holdings Limited Vaccines formed by virus and antigen conjugation
IL279295B2 (en) 2018-06-12 2026-03-01 Kentucky Bioprocessing Inc Purification and cross-linking of virus and antigen
JP2021533831A (ja) * 2018-08-16 2021-12-09 スペースクラフト セブン リミテッド ライアビリティ カンパニー ウイルスベクターのための生成方法
US20220175962A1 (en) 2019-03-10 2022-06-09 Sio Gene Therapies Inc. Gene therapy compositions and methods for treating parkinson's disease
US20220243224A1 (en) * 2019-04-15 2022-08-04 Children's Hospital Medical Center Viral vector manufacturing methods
US12037599B2 (en) 2019-08-23 2024-07-16 Lonza Walkersville, Inc. Methods and constructs for production of lentiviral vector
JP7803014B2 (ja) 2019-09-30 2026-01-21 バイオベラティブ セラピューティクス インコーポレイテッド レンチウイルスベクター製剤
WO2021094752A1 (en) 2019-11-12 2021-05-20 Oxford Biomedica (Uk) Limited Production system
JP2023513303A (ja) 2020-02-13 2023-03-30 オックスフォード バイオメディカ（ユーケー）リミテッド レンチウイルスベクターの製造
US20230118587A1 (en) 2020-03-13 2023-04-20 Oxford Biomedica (Uk) Limited Lentiviral Vectors
CN116096430A (zh) 2020-04-27 2023-05-09 衣阿华大学研究基金会 用于治疗囊性纤维化的组合物和方法
GB202007199D0 (en) 2020-05-15 2020-07-01 Oxford Biomedica Ltd Viral vector production
US12173307B2 (en) 2020-06-24 2024-12-24 Bioverativ Therapeutics Inc. Methods for the purification of viral vectors
AU2021324776A1 (en) * 2020-08-13 2023-04-13 Tmunity Therapeutics Inc. Methods for producing clinical-grade lentiviral vector
CN112226418B (zh) * 2020-09-25 2022-07-08 阜外华中心血管病医院 重组腺相关病毒纯化方法
CN116529382A (zh) * 2020-10-02 2023-08-01 吉恩勒克斯公司 由贴壁细胞在生物反应器中产生病毒
GB202017725D0 (en) 2020-11-10 2020-12-23 Oxford Biomedica Ltd Method
CN112899242A (zh) * 2021-02-03 2021-06-04 苏州博腾生物制药有限公司 慢病毒纯化工艺
GB202114532D0 (en) 2021-10-12 2021-11-24 Oxford Biomedica Ltd Lentiviral Vectors
GB202114529D0 (en) 2021-10-12 2021-11-24 Oxford Biomedica Ltd Lentiviral vectors
GB202114528D0 (en) 2021-10-12 2021-11-24 Oxford Biomedica Ltd Lentiviral vectors
GB202114534D0 (en) 2021-10-12 2021-11-24 Oxford Biomedica Ltd Novel viral regulatory elements
GB202114530D0 (en) 2021-10-12 2021-11-24 Oxford Biomedica Ltd Retroviral vectors
EP4424705A4 (en) 2021-10-29 2026-02-18 Agc Inc Composition for adding cells
WO2023085382A1 (ja) 2021-11-12 2023-05-19 Ａｇｃ株式会社 ウイルスの精製方法
GB202117844D0 (en) 2021-12-09 2022-01-26 Oxford Biomedica Ltd Purification method
GB202211935D0 (en) 2022-08-16 2022-09-28 Oxford Biomedica Ltd envelope proteins
CN116240241A (zh) * 2022-12-30 2023-06-09 上海本导基因技术有限公司 重组慢病毒载体的纯化制备方法
CN121002189A (zh) * 2023-02-01 2025-11-21 因特尔乌斯生物治疗公司 用于过滤或纯化病毒颗粒的方法
WO2024259299A1 (en) 2023-06-14 2024-12-19 The Broad Institute, Inc. Compositions and methods for identification of vhh antibodies that bind a target antigen
WO2025235738A1 (en) * 2024-05-08 2025-11-13 Interius Biotherapeutics, Inc. Methods of detecting residual dna in viral preparations

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL78703A (en) 1985-05-10 1993-02-21 Benzon Alfred Method of producing extracellular enzymes, the enzymes produced thereby and compositions containing them; a hybrid plasmid and a dna fragment comprising dna encoding the enzymes; a microorganism harbouring the plasmid; and a method for removing nucleic acids from biological materials
DE4006630A1 (de) 1990-03-03 1991-09-12 Behringwerke Ag Humane monoklonale antikoerper gegen tollwutviren, ihre herstellung und verwendung
DE69131908T3 (de) 1991-02-19 2008-04-03 Oxford Biomedica (Uk) Ltd. Viruspartikel mit veraendertem wirtspektrum
US5512421A (en) 1991-02-19 1996-04-30 The Regents Of The University Of California Generation, concentration and efficient transfer of VSV-G pseudotyped retroviral vectors
EP0738319A4 (en) * 1994-01-12 2000-03-29 Genetic Therapy Inc Purification of retroviral vectors
DE69515028T2 (de) 1994-03-22 2000-06-29 The Immune Response Corp., Carlsbad Die hocheffiziente herstellung und isolierung von viruspartikeln
US5681746A (en) 1994-12-30 1997-10-28 Chiron Viagene, Inc. Retroviral delivery of full length factor VIII
US5837520A (en) 1995-03-07 1998-11-17 Canji, Inc. Method of purification of viral vectors
US5723315A (en) 1996-08-23 1998-03-03 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
US6100071A (en) 1996-05-07 2000-08-08 Genentech, Inc. Receptors as novel inhibitors of vascular endothelial growth factor activity and processes for their production
DE69729007T2 (de) 1996-08-07 2005-04-07 Darwin Discovery Ltd., Slough Hydroxamsäure- und carbonsäure-derivate mit mmp und tnf hemmender wirkung
US6126939A (en) 1996-09-03 2000-10-03 Yeda Research And Development Co. Ltd. Anti-inflammatory dipeptide and pharmaceutical composition thereof
WO1999061639A2 (en) 1998-05-22 1999-12-02 Oxford Biomedica (Uk) Limited Retroviral delivery system
PL332875A1 (en) 1996-10-17 1999-10-25 Oxford Biomedica Ltd Retroviral vectors
ES2278399T3 (es) * 1996-11-20 2007-08-01 Introgen Therapeutics, Inc. Metodo mejorado para la produccion y purificacion de vectores adenovirales.
US6261823B1 (en) 1996-12-13 2001-07-17 Schering Corporation Methods for purifying viruses
GB9720465D0 (en) 1997-09-25 1997-11-26 Oxford Biomedica Ltd Dual-virus vectors
GB9803351D0 (en) 1998-02-17 1998-04-15 Oxford Biomedica Ltd Anti-viral vectors
GB9904905D0 (en) 1999-03-03 1999-04-28 Oxford Biomedica Ltd Cells
GB0009760D0 (en) 2000-04-19 2000-06-07 Oxford Biomedica Ltd Method
GB0024550D0 (https=) 2000-10-06 2000-11-22 Oxford Biomedica Ltd
JP2005521417A (ja) * 2002-03-29 2005-07-21 メルク　エンド　カムパニー　インコーポレーテッド アデノウイルスの大規模産生方法及びアデノウイルス種子ストック
DE60335672D1 (de) 2002-05-14 2011-02-17 Merck Sharp & Dohme Verfahren zur reinigung von adenovirus
JP4992032B2 (ja) 2002-09-03 2012-08-08 オックスフォード バイオメディカ（ユーケー）リミテッド レトロウイルスベクター
ATE488252T1 (de) 2003-05-05 2010-12-15 Virxsys Corp Erhöhte transduktion mit abc- transportersubstratenhemmern
SE0302509D0 (sv) 2003-09-19 2003-09-19 Amersham Biosciences Ab Matrix for separation of polyethers and method of separation
WO2005039643A2 (en) * 2003-10-20 2005-05-06 Nsgene A/S In vivo gene therapy of parkinson's disease
NZ548495A (en) * 2004-02-23 2009-05-31 Crucell Holland Bv Virus purification methods
GB0526211D0 (en) 2005-12-22 2006-02-01 Oxford Biomedica Ltd Viral vectors
GB0526210D0 (en) 2005-12-22 2006-02-01 Oxford Biomedica Ltd Vectors
PL2007883T3 (pl) 2006-04-20 2012-07-31 Wyeth Llc Sposób oczyszczania do izolacji oczyszczonego wirusa pęcherzykowatego zapalenia jamy ustnej z hodowli komórkowej
EP2091966A2 (en) * 2006-12-01 2009-08-26 Oxford BioMedica (UK) Limited Promoter construct
CA2678774A1 (en) * 2007-03-01 2008-09-04 Advanced Vision Therapies, Inc. Treatment of diseases characterized by inflammation
CA2705850C (en) * 2007-11-13 2016-07-19 Bio-Technology General (Israel) Ltd. Dilute filtration sterilization process for viscoelastic biopolymers

Similar Documents

Publication Publication Date Title
JP2011524887A5 (https=)
CN101972479B (zh) 一种静注人免疫球蛋白的制备工艺
CN104371982A (zh) 一种慢病毒的纯化方法
KR102364111B1 (ko) 세포 배양물로부터 폴리오바이러스의 정제 방법
CN105601736B (zh) 一种抗呼吸道合胞病毒人免疫球蛋白及其制备方法
US20160122414A1 (en) Method for extracting recombinant human serum albumin from transgenic rice grain
JP2023528657A (ja) 発酵ブロスの改善された脱塩及び例えばオリゴ糖のファインケミカルの精製
WO2020127140A1 (en) Method for separating biomass from a solution comprising biomass and at least one oligosaccaride
US20260085294A1 (en) Process for producing a purified rhabdovirus from cell culture
US20210277363A1 (en) Manufacture of Virus
CN108484422B (zh) 从酶转化液中提取β-丙氨酸的纯化结晶工艺及其系统
CN116621948B (zh) 一种重组呼吸道合胞病毒f蛋白的纯化工艺方法
CN108368162A (zh) 一种重组人粒细胞刺激因子的复性及纯化方法
CN111662883A (zh) 一种制备及纯化溶瘤病毒的方法及重组溶瘤弹状病毒
CN112625120B (zh) 连续规模化生产重组胶原蛋白的工艺
CN111094309A (zh) 高纯度核黄素磷酸钠的制备方法
CN119799632A (zh) 一种功能增强的间充质干细胞外泌体的制备方法及其应用
JP3989866B2 (ja) ヒアルロン酸又は／及びキチンの分離・精製方法
CN118389625A (zh) 一种从果糖溶液中联产氨基葡萄糖盐酸盐和d-阿洛酮糖的方法
WO2025157970A1 (en) Large scale methods for producing plasmid dna
CN117660373A (zh) 一种慢病毒大规模纯化方法及其应用
EA049917B1 (ru) Способ получения очищенного рабдовируса из клеточной культуры
CN106046127A (zh) 一种白喉类毒素的制备方法
CN112209999A (zh) 一种快速分离重组表皮生长因子发酵液中色素的方法
UA52744U (uk) Спосіб одержання антигену для діагностики лейкозу великої рогатої худоби в реакції імунодифузії (рід)